Maria M Bausili1, Harish Raja, Jacek Kotowski, Jeroni Nadal, Diva R Salomao, Deborah Keenum, Jose S Pulido. 1. *Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota; †The Barraquer Eye Institute, Barcelona, Spain; ‡Department of Pathology, Mayo Clinic, Rochester, Minnesota; §Department of Ophthalmology, Billings Clinic, Billings, Montana; and ¶Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND/ PURPOSE: To report a new technique for treating patients with uveal effusion syndrome by the fiberoptic-guided CO2 laser. METHODS: Interventional case report. A 74-year-old man presented with exudative detachment of the choroid secondary to uveal effusion syndrome. Partial-thickness sclerotomy and full-thickness sclerotomy were performed to treat the disease using a fiberoptic-guided CO2 laser. RESULTS: After the surgery, the patient's visual acuity improved and choroidal folds disappeared. CONCLUSION: This technique allows concomitant coagulation and cutting, thereby reducing the risk of bleeding and providing better depth control.
BACKGROUND/ PURPOSE: To report a new technique for treating patients with uveal effusion syndrome by the fiberoptic-guided CO2 laser. METHODS: Interventional case report. A 74-year-old man presented with exudative detachment of the choroid secondary to uveal effusion syndrome. Partial-thickness sclerotomy and full-thickness sclerotomy were performed to treat the disease using a fiberoptic-guided CO2 laser. RESULTS: After the surgery, the patient's visual acuity improved and choroidal folds disappeared. CONCLUSION: This technique allows concomitant coagulation and cutting, thereby reducing the risk of bleeding and providing better depth control.
Authors: Carol L Shields; Kelsey Roelofs; Maura Di Nicola; Kareem Sioufi; Arman Mashayekhi; Jerry A Shields Journal: Indian J Ophthalmol Date: 2017-11 Impact factor: 1.848